Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
JG Boswell stock logo
BWEL
JG Boswell
$587.00
-0.1%
$593.16
$571.02
$725.00
N/AN/A145 shs185 shs
Clariant AG stock logo
CLZNF
Clariant
$13.97
$13.24
$12.89
$15.70
N/AN/A2,333 shsN/A
LG Chem Ltd. stock logo
LGCLF
LG Chem
$280.00
$280.00
$0.00
$0.00
N/AN/AN/AN/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
$28.12
$27.17
$21.47
$40.67
N/AN/A1,000 shsN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
$0.09
-5.1%
$0.12
$0.03
$0.28
N/AN/A80,886 shs141,252 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
JG Boswell stock logo
BWEL
JG Boswell
-0.09%+0.69%-0.68%-1.84%-17.90%
Clariant AG stock logo
CLZNF
Clariant
0.00%0.00%+8.35%+6.20%-11.05%
LG Chem Ltd. stock logo
LGCLF
LG Chem
0.00%0.00%0.00%0.00%0.00%
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
0.00%-1.68%+2.25%-1.02%-27.90%
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
-5.12%-10.68%-52.87%-27.09%+28.66%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/AN/AN/AN/AN/A
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/AN/AN/AN/AN/AN/AN/AN/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
N/AN/AN/AN/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/A
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/AN/AN/AN/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
2.00
HoldN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/AN/AN/A
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/AN/AN/AN/AN/AN/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
N/AN/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
JG Boswell stock logo
BWEL
JG Boswell
N/AN/A0.00N/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/A$0.4729.95N/AN/AN/AN/AN/A
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/AN/A0.00N/AN/AN/AN/AN/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
N/A-$1.03N/AN/AN/AN/AN/AN/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/A0.00N/AN/AN/AN/A6/29/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/AN/AN/A
Clariant AG stock logo
CLZNF
Clariant
N/AN/AN/AN/AN/A
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/AN/AN/AN/AN/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
$0.501.78%N/AN/A N/A
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
JG Boswell stock logo
BWEL
JG Boswell
N/A
Clariant AG stock logo
CLZNF
Clariant
31.17%
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/A
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
36.83%
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
JG Boswell stock logo
BWEL
JG Boswell
N/AN/AN/ANot Optionable
Clariant AG stock logo
CLZNF
Clariant
10,481N/AN/ANot Optionable
LG Chem Ltd. stock logo
LGCLF
LG Chem
N/AN/AN/ANot Optionable
LANXESS Aktiengesellschaft stock logo
LNXSF
LANXESS Aktiengesellschaft
10,981N/AN/ANot Optionable
Nascent Biotech, Inc. stock logo
NBIO
Nascent Biotech
4N/AN/ANot Optionable

NBIO, BWEL, CLZNF, LNXSF, and LGCLF Headlines

SourceHeadline
Nascent Biotech prepares for pivotal Phase II research with fresh manufacturing runNascent Biotech prepares for pivotal Phase II research with fresh manufacturing run
msn.com - April 16 at 3:45 PM
Nascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing RunNascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
finanznachrichten.de - April 16 at 8:23 AM
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing RunNascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
accesswire.com - April 16 at 8:00 AM
Nascent Biotech, Inc. (OTCMKTS:NBIO) Short Interest Up 21.8% in MarchNascent Biotech, Inc. (OTCMKTS:NBIO) Short Interest Up 21.8% in March
americanbankingnews.com - April 15 at 6:18 AM
Nascent Biotech Inc.: Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery SystemNascent Biotech Inc.: Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
finanznachrichten.de - March 19 at 12:57 PM
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery SystemNascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
accesswire.com - March 19 at 8:00 AM
Nascent Biotech Inc NBIONascent Biotech Inc NBIO
morningstar.com - March 2 at 2:35 PM
Nascent Biotech, Manhattan Bio collaborate to explore pritumumab antibody-drug conjugatesNascent Biotech, Manhattan Bio collaborate to explore pritumumab antibody-drug conjugates
pharmabiz.com - February 8 at 2:18 AM
Nascent Biotech Inc.: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug ConjugatesNascent Biotech Inc.: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
finanznachrichten.de - February 6 at 10:09 AM
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug ConjugatesNascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
finance.yahoo.com - February 6 at 10:09 AM
Nascent Biotech Inc.: Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under ValuedNascent Biotech Inc.: Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
finanznachrichten.de - January 10 at 8:43 AM
Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under ValuedNascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
finance.yahoo.com - January 9 at 9:25 AM
Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution RiskNascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
finance.yahoo.com - December 19 at 12:10 PM
Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain BarrierNascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier
finance.yahoo.com - November 29 at 9:37 AM
West Coast investor Red Tree on its San Diego expansion and staying bullish in biotechWest Coast investor Red Tree on its San Diego expansion and staying bullish in biotech
biopharmadive.com - November 16 at 12:58 PM
Isana Nascent AcademyIsana Nascent Academy
usnews.com - November 15 at 8:20 PM
Concord Biotech hits record high after Jefferies initiates buy call; sees 19% upsideConcord Biotech hits record high after Jefferies initiates 'buy' call; sees 19% upside
moneycontrol.com - November 1 at 1:55 AM
Chicago to showcase its biotech sector at capital summit next weekChicago to showcase its biotech sector at capital summit next week
bizjournals.com - October 26 at 6:07 PM
A tropical storm could threaten Florida next week. Here’s what we know.A tropical storm could threaten Florida next week. Here’s what we know.
washingtonpost.com - September 2 at 5:04 AM
Nascent Biotech to Begin Phase II Clinical Trials for Brain CancerNascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
finance.yahoo.com - August 22 at 8:18 AM
Nascent Project: Open Source Scanning Electron MicroscopeNascent Project: Open Source Scanning Electron Microscope
hackaday.com - July 21 at 8:09 PM
Nascent Biotech Inc.: Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual MeetingNascent Biotech Inc.: Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting
finanznachrichten.de - June 7 at 9:46 AM
Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual MeetingNascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting
bignewsnetwork.com - June 7 at 9:46 AM
Nascent Biotech Inc.: Nascent Biotech Regains Worldwide Rights for PritumumabNascent Biotech Inc.: Nascent Biotech Regains Worldwide Rights for Pritumumab
finanznachrichten.de - May 26 at 7:13 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

JG Boswell logo

JG Boswell

OTCMKTS:BWEL
JG Boswell Company produces, processes, and markets pima cotton. It is also involved in processing tomatoes for paste and seed crops, as well as livestock operations in Central California. The company was founded in 1925 and is headquartered in Pasadena, California.
Clariant logo

Clariant

OTCMKTS:CLZNF
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in automotive fluids, aviation, construction chemicals, crop solutions, health care, home care, industrial lubricants, paints and coatings, personal care, and special solvents. The Catalysis segment provides catalyst products for use as ammonia cracking, ammonia, custom catalysts, ethylene and derivatives, fischer-tropsch, fuel cell, fuel upgrading, gas processing, hydrogen, hydrogenation, liquid hydrogen carrier, low-carbon ammonia, low-carbon methanol, methanol, methanol-to-propylene, off-gas treatment, olefins purification, on-purpose propylene, oxidation, polypropylene, refinery stream purification, styrene, zeolite powders, biocatalysis, cellulosic ethanol, cellulosic sugars, low-carbon advanced biofuels, and residue-derived biochemical intermediates. The Adsorbents and Additives segment provides chemicals for oil, gas, mining, and refinery industries; services for oil and gas industries; emulsifiers for explosives, as well as cold-flow additive applications for middle distillates in refineries; mineral-based specialty products for bio- and renewable fuel purification, BTX catalysts, cargo and device protection, cat litter, chemical recycling, civil engineering, clay specialties, detergent additives, edible oil purification, feed additives, foundry additives, kerosene and jet fuel purification, paper additives, PVC stabilizers, and wastewater treatment applications; and flame retardants, performance additives, and advanced surface solutions for use in acid scavengers, antioxidiants, antistatic agents, halogen-free flame retardants, heat stabilizers, hot-melt adhesives, light stabilizers, lubricants, processing aids, processing stabilizers, release agents, slip control agents, and surface modifiers. The company was founded in 1886 and is headquartered in Muttenz, Switzerland.
LG Chem logo

LG Chem

OTCMKTS:LGCLF
LG Chem Ltd. manufactures petrochemicals, IT & electronic materials and energy solution materials. It operates through through the following business segments: Petrochemicals, IT & Electronic Materials, Batteries. The Petrochemical division offers naphtha cracking centers and polyolefins, synthetic rubbers and specialty polymers, polyvinyl chloride, acrylonitrile-butadiene-styrene and engineering plastics, acrylates and plasticizers. The IT & Electronic Material division provides optical and display materials namely polarizers, phosphors, organic light emitting diode, photosensitive materials for liquid crystal display; printed circuit materials such as flexible materials, halogen free materials, integrated circuit packaging materials, epoxy resin system materials, high speed materials and build-up materials; toners such as color toners, black laser printer toners and black copier toners. The Battery division provides lithium-ion cylindrical batteries, lithium-ion polymer batteries, lithium-ion prismatic batteries, medium and large batteries. The company was founded in January 1947 and is headquartered in Seoul, South Korea.
LANXESS Aktiengesellschaft logo

LANXESS Aktiengesellschaft

OTCMKTS:LNXSF
LANXESS Aktiengesellschaft, together with its subsidiaries, operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The Consumer Protection segment provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. The Specialty Additives segment offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for a variety of applications in for the rubber, plastic and paint, electrical/electronics, and construction industries. The Advanced Intermediates segment provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials as well as paints and coatings. The segment serves agrochemical, automotive, construction, aromas and flavors, semiconductors and photovoltaic, and color pigments industries. LANXESS Aktiengesellschaft was founded in 1863 and is headquartered in Cologne, Germany.
Nascent Biotech logo

Nascent Biotech

OTCMKTS:NBIO
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.